Related Experiment Video
Updated: Jul 7, 2026

Multiplexed Fluorescent Immunohistochemical Staining of Four Endometrial Immune Cell Types in Recurrent Miscarriage
Published on: August 4, 2021
Evaluation and management of recurrent early pregnancy loss
Mary Stephenson1, William Kutteh
1Section of Reproductive Endocrinology and Infertility, University of Chicago, Chicago, Illinois, USA. mstephen@babies.bsd.uchicago.edu
Abstract:
Recurrent pregnancy loss affects up to 5% of couples trying to establish a family. Evaluation classically begins after 3 consecutive miscarriages of less than 10 weeks of gestation but may be warranted earlier if a prior miscarriage was found to be euploid, or if there is concomitant infertility and/or advancing maternal age. The evaluation begins with an extensive history and physical, followed by a diagnostic screening protocol. Management must be evidence-based; unproven treatments should be avoided. If no factor is identified, many couples will still eventually have a successful pregnancy outcome with supportive therapy alone.
More Related Videos
07:46Platform for Quantitative Detection of Endometrial Immune Cells Based on Immunohistochemistry and Digital Image Analysis
Published on: October 13, 2023
08:29Measurement of Four Uterine NK Cell Subtypes Using Multiplexed Fluorescent Immunohistochemical Staining in Women with Repeated Implantation Failure
Published on: October 25, 2024
Related Concept Videos
Ovarian Cycle
Mitral Valve Prolapse II: Assessment and Management
Mitral Valve Prolapse III: Nursing Management